A study with commercial herbal supplement FastOneTM showed an increase of both EROD activity and protein level of CYP1A2, and thus suggests that intake of the herbal supplement may increase the risk of colorectal cancer in humans with the rapid NAT2 phenotype (Ryu and Chung, 2003). Here, CYP1A2 is linked to colorectal cancer.